Gastric mucosal blood flow and acid secretory changes in man with impromidine: a new specific histamine-H2-receptor agonist.
R L McIsaac, B J Johnston, and L P Fielding
Gut 1981; 22: 529-533. doi:10.1136/gut.22.7.529
[Abstract]
[PDF]
[Request Permissions]
Ultrastructure of endocrine-like cells in lamina propria of human gastric mucosa.
J Stachura, W J Krause, and K J Ivey
Gut 1981; 22: 534-541. doi:10.1136/gut.22.7.534
[Abstract]
[PDF]
[Request Permissions]
Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine.
W Londong, V Londong, C Ruthe, and P Weizert
Gut 1981; 22: 542-548. doi:10.1136/gut.22.7.542
[Abstract]
[PDF]
[Request Permissions]
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
R G Long, J R Peters, S R Bloom, M R Brown, W Vale, J E Rivier, and D G Grahame-Smith
Gut 1981; 22: 549-553. doi:10.1136/gut.22.7.549
[Abstract]
[PDF]
[Request Permissions]
Changes in N-terminal glucagon-like immunoreactivity and insulin during short-term gluten challenge in childhood coeliac disease.
D J Carson, J F Glasgow, K D Buchanan, and J M Sloan
Gut 1981; 22: 554-557. doi:10.1136/gut.22.7.554
[Abstract]
[PDF]
[Request Permissions]
Prolactin and the small intestine. Effect of hyperprolactinaemia on mucosal structure in the rat.
E Muller and R H Dowling
Gut 1981; 22: 558-565. doi:10.1136/gut.22.7.558
[Abstract]
[PDF]
[Request Permissions]
In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique.
R D'Amelio, P Rossi, S Le Moli, R Ricci, S Montano, and F Pallone
Gut 1981; 22: 566-570. doi:10.1136/gut.22.7.566
[Abstract]
[PDF]
[Request Permissions]
Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.
C Andre, L Descos, P Landais, and J Fermanian
Gut 1981; 22: 571-574. doi:10.1136/gut.22.7.571
[Abstract]
[PDF]
[Request Permissions]
Changes in glucose tolerance after endoscopic retrograde cholangiopancreatography.
Z Tulassay, J Papp, M Szathmári, S Kisfaludy, L Korányi, and G Tamás
Gut 1981; 22: 575-578. doi:10.1136/gut.22.7.575
[Abstract]
[PDF]
[Request Permissions]
Biliary lipids, faecal steroids, and liver function in patients with chronic active hepatitis and primary biliary cirrhosis: significance of hepatic orcein-stained complexes.
Y A Kesäniemi, T A Miettinen, and M P Salaspuro
Gut 1981; 22: 579-584. doi:10.1136/gut.22.7.579
[Abstract]
[PDF]
[Request Permissions]
Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis.
H Ring-Larsen and U Palazzo
Gut 1981; 22: 585-591. doi:10.1136/gut.22.7.585
[Abstract]
[PDF]
[Request Permissions]
Pregnancy and liver disease.
M M Steven
Gut 1981; 22: 592-614. doi:10.1136/gut.22.7.592
[PDF]
[Request Permissions]